News and Announcements
Universal Biosensors Product Update
- Published April 01, 2016 3:36PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
1st April 2016, ASX Announcement
Universal Biosenors (ASX:UBI) provides below an update to its product development pipeline.
The company has been conducting a review of its current development projects with a view to prioritising development spend and focusing on projects that most enhance shareholder value.
Associated with this review, UBI management have also noted the eligibility criteria to access the R&D cash rebate which is important to UBI’s net cash flow. In particular, it is a condition of the program that the annual revenue remains below $20 million. It makes very little sense for UBI to chase short term small revenue increases that will take our revenue above this limit.
To view the full article please click on the button below.